In this issue:
Factor XI deficiency decreases CV and venous thromboembolism risk
Rivaroxaban or fondaparinux for preventing thromboembolism in superficial-vein thrombosis
Frailty classifications in older patients with cancer
Adding lestaurtinib to first-line chemotherapy in FLT3-mutated AML
Copy-number analysis identifies new prognostic marker in AML
Higher treatment facility volume reduces MM mortality
Eltrombopag for low-risk myelodysplastic syndromes with thrombocytopenia
PDUS-guided biopsy for characterising lymphadenopathies in suspected lymphoma
Low-dose pembrolizumab improves relapsed/refractory Hodgkin’s lymphoma outcomes
Please login below to download this issue (PDF)